As a part of Indutrade's strategy for continued sustainable profitable growth, and to intensify the development of the MedTech/Pharma businesses, Morgan O'Brien has been appointed SVP Business Development & President UltraPure International (UPI). The newly established position will be a part of Indutrade's Group Management. Morgan O'Brien, currently SVP of the Business Area Flow Technology, has during the last years played a key role in the development and growth of Indutrade's MedTech segment, particularly within the single-use niche. The companies involved in the UPI/single-use business will remain in their respective Business Areas, hence there will be no change in terms of company reporting structures. Per-Olow Jansson has been named successor to Morgan O'Brian, as SVP of the Business Area Flow Technology, and joins Indutrade's Group Management. In his most recent position, as Managing Director of the Indutrade company GPA Flowsystem AB, Per-Olow Jansson led the GPA Group of approximately 120 employees in Sweden, Denmark and Norway. He has also been a Business Unit leader with a responsibility as Chairman for a cluster of companies in Scandinavia and Great Britain. Morgan O'Brien and Per-Olow Jansson will take up their new positions effective 1 July 2021.